Ladrx corporation issues corporate update for 3q22

Los angeles--( business wire )--ladrx corporation (otcqb: ladx) (“ladrx” or the “company”), a biopharmaceutical innovator focused on research and development of life-saving cancer therapeutics, today issued the below update to stockholders.

IBRX Ratings Summary

IBRX Quant Ranking